WHO ICTRP trial
Effect of a program on drug use in patients with Ulcerative Colitis
RBR-79dn4k · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting
Key facts
| Trial ID | RBR-79dn4k |
|---|---|
| Public title | Effect of a program on drug use in patients with Ulcerative Colitis |
| Scientific title | Impact of an intervention program on nonadherence to drugs in Ulcerative Colitis Patients: randomized clinical trial |
| Primary sponsor | Universidade do Estado da Bahia |
| Secondary sponsors | Programa de Pós-Graduação em Ciências Farmacêuticas - PPGFARMA |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | Proctocolitis; Medication Adherence;C06.405.205.265.767;F01.100.150.750.500.600.500 |
| Interventions | Intervention program with educational and behavioral measures Intervention Program The program will last 6 months, with each intervention having its frequency as listed below. Participants in the CG will not receive the interventions, while… |
| Registration date | Feb 1, 2020 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: